Rain Oncology Inc. Operating Cash Flow
Rain Oncology Inc. reported Operating Cash Flow of -$52.46 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2023-11-09
- Rain Oncology Inc. net cash provided by (used in) operating activities for the quarter ending 2023-09-30 was -$7.00M.
- Rain Oncology Inc. net cash provided by (used in) operating activities for the quarter ending 2023-06-30 was -$23.62M.
- Rain Oncology Inc. net cash provided by (used in) operating activities for the quarter ending 2023-03-31 was -$21.84M.
- Rain Oncology Inc. net cash provided by (used in) operating activities for the quarter ending 2022-12-31 was -$13.29M.
- Rain Oncology Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$63.20M.
- Rain Oncology Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$37.46M.
- Rain Oncology Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$11.23M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$30.62M derived: sum of 2 quarters · filed 2023-11-09 | -$52.46M 10-Q · filed 2023-11-09 | -$65.76M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | -$23.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$45.46M 10-Q · filed 2023-08-10 | -$58.76M derived: sum of 3 quarters · filed 2023-08-10 | -$74.12M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-03-31 | -$21.84M 10-Q · filed 2023-05-11 | -$35.13M derived: sum of 2 quarters · filed 2023-05-11 | -$50.50M derived: sum of 3 quarters · filed 2023-11-09 | -$67.93M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-12-31 | -$13.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$28.66M derived: sum of 2 quarters · filed 2023-11-09 | -$46.09M derived: sum of 3 quarters · filed 2023-11-09 | -$63.20M 10-K · filed 2023-03-09 |
| 2022-09-30 | -$15.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$32.80M derived: sum of 2 quarters · filed 2023-11-09 | -$49.91M 10-Q · filed 2023-11-09 | -$59.66M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$17.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$34.54M 10-Q · filed 2023-08-10 | -$44.30M derived: sum of 3 quarters · filed 2023-08-10 | -$56.26M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$17.11M 10-Q · filed 2023-05-11 | -$26.87M derived: sum of 2 quarters · filed 2023-05-11 | -$38.82M derived: sum of 3 quarters · filed 2023-05-11 | -$49.71M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$9.76M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$21.71M derived: sum of 2 quarters · filed 2023-03-09 | -$32.60M derived: sum of 3 quarters · filed 2023-03-09 | -$37.46M 10-K · filed 2023-03-09 |
| 2021-09-30 | -$11.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$22.84M derived: sum of 2 quarters · filed 2022-11-10 | -$27.70M 10-Q · filed 2022-11-10 | -$32.16M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$10.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$15.75M 10-Q · filed 2022-08-04 | -$20.21M derived: sum of 3 quarters · filed 2022-08-04 | -$22.56M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$4.87M 10-Q · filed 2022-05-04 | -$9.32M derived: sum of 2 quarters · filed 2022-05-04 | -$11.67M derived: sum of 3 quarters · filed 2022-05-04 | -$13.61M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | -$4.46M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$6.81M derived: sum of 2 quarters · filed 2022-03-03 | -$8.74M derived: sum of 3 quarters · filed 2022-03-03 | -$11.23M 10-K · filed 2022-03-03 |
| 2020-09-30 | -$2.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$4.29M derived: sum of 2 quarters · filed 2021-11-10 | -$6.78M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$4.42M 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | -$2.49M 10-Q · filed 2021-05-25 |